Aktie A0F457 IMV CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen IMV Corporation

Aktien

A0F457

JP3100760002

7760

Markt geschlossen - Japan Exchange
Andere Börsenplätze
 08:00:00 10.05.2024 		% 5 Tage % 1. Jan.
608 JPY -5,74 % Intraday Chart für IMV Corporation -4,70 % +16,70 %
25.03. BioVaxys Technology plant Privatplatzierung; Rückgang um 5,9% MT
2023 IMV Corporation (TSE:7760) kündigt einen Aktienrückkauf für 400.000 Aktien an, was 2,45% für ¥250 Millionen entspricht. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Tranche Update on IMV Corporation's Equity Buyback Plan announced on November 21, 2023.
BioVaxys Technology Plans Private Placement; Down 5.9%
Biovaxys Completes The Acquisition Of All Intellectual Property And Clinical Stage Assets Of The Former IMV Inc.
BioVaxys Acquires Entire Technology Portfolio Of The Former IMV Inc.
Tranche Update on IMV Corporation's Equity Buyback Plan announced on November 21, 2023.
IMV Corporation announces an Equity Buyback for 400,000 shares, representing 2.45% for ¥250 million.
IMV Corporation authorizes a Buyback Plan.
IMV Corporation Reports Earnings Results for the Full Year Ended September 30, 2023
EKF Diagnostics hires CFO from Trellus Health, latter names successor
Trellus Health's Interim Finance Head Takes Full-time CFO Role at EKF Diagnostics
Imv Corporation Provides Dividend Guidance for the Fiscal Year Ending September 30, 2023
Imv Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2023
IMV Corporation Reports Earnings Results for the Half Year Ended March 31, 2023
IMV Receives Delisting Notice From Nasdaq Over Bankruptcy Proceedings in Canada
IMV Inc. Brief: Says Received NASDAQ Delisting Notice
IMV Inc. Brief: Says Received Nasdaq Notification Regarding Minimum Bid Price Deficiency
IMV Inc. Details Board Changes
IMV Inc. Brief: Hall Adds Co engaged Stonegate to explore strategic alternatives, "So that MVP-S can realize its full clinical potential"
IMV Inc. Brief: Andrew Hall, Chief Executive Officer, Said" "The market headwinds limiting available capital are, however, very real"
IMV Inc. Brief: Net loss and comprehensive loss of US$38.0 million ($4.55 per share) for Year ended December 31, 2022, Vs net loss and comprehensive loss of $36.6 ($4.93 per share) for Year ended December 31, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0F457 Aktie
  4. Nachrichten IMV Corporation
  5. Andere Sprachen